Eric T Wittbrodt (Eric Wittbrodt)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 9

Top Topics

Glycemic Control

Ejection Fraction

Top Venues

Diabetes, obesity & metabolism

Journal of medical Internet research

Journal of patient experience

International journal of nephrology and renovascular disease

This page only lists publications with an associated author ORCID identifier.

Publications

Susan Grandy, Eirini Palaka, Nicolas Guzman, Alicia Dunn, Eric T Wittbrodt, Fredric O Finkelstein
Understanding Patient Perspectives of the Impact of Anemia in Chronic Kidney Disease: A United States Patient Survey. Journal of patient experience 9 (2022)
Chuan-Ming Hao, Eric T Wittbrodt, Eirini Palaka, Nicolas Guzman, Alicia Dunn, Susan Grandy
Understanding Patient Perspectives and Awareness of the Impact and Treatment of Anemia with Chronic Kidney Disease: A Patient Survey in China. International journal of nephrology and renovascular disease 14 (2021)
Carolyn Su Ping Lam, Avraham Karasik, Cheli Melzer Cohen, Matthew A Cavender, Shun Kohsaka, Anna Norhammar, Marcus Thuresson, Hungta Chen, Eric T Wittbrodt, Peter Fenici, Mikhail Kosiborod, null null
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study. Diabetes, obesity & metabolism 23 (6) (2021)
Eun Sil Koh, Kyungdo Han, You-Seon Nam, Eric T Wittbrodt, Peter Fenici, Mikhail Naum Kosiborod, Hiddo J Lambers Heerspink, Soon-Jib Yoo, Hyuk-Sang Kwon
Renal outcomes and all-cause death associated with sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL 3 Korea). Diabetes, obesity & metabolism 23 (2) (2020)
Glen James, Elisabeth Nyman, Marcy Fitz-Randolph, Anna Niklasson, Katarina Hedman, Jonatan Hedberg, Eric T Wittbrodt, Jennie Medin, Carol Moreno Quinn, Alaster M Allum, Cathy Emmas
Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study. Journal of medical Internet research 22 (7) (2020)
Phil McEwan, Hayley Bennett, Kamlesh Khunti, John P H Wilding, Christopher Edmonds, Marcus Thuresson, Eric T Wittbrodt, Peter Fenici, Mikhail Naum Kosiborod
Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence. Diabetes, obesity & metabolism 22 (12) (2020)
Eric T Wittbrodt, Narinder Bhalla, Karolina Andersson Sundell, Qi Gao, Liyan Dong, Matthew A Cavender, Phillip R Hunt, Nathan D Wong, Carl Mellström
Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry. Endocrinology, diabetes & metabolism 3 (3) (2020)
Eric T Wittbrodt, David Chamberlain, Suzanne V Arnold, Fengming Tang, Mikhail Naum Kosiborod
Eligibility of patients with type 2 diabetes for sodium-glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry. Diabetes, obesity & metabolism 21 (8) (2019)
Julie C Lauffenburger, Roya Ghazinouri, Saira Jan, Sagar Makanji, Christina A Ferro, Jennifer Lewey, Eric T Wittbrodt, Jessica Lee, Nancy Haff, Constance P Fontanet, Niteesh K Choudhry
Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial. PloS one 14 (4) (2019)